RIZZA, PIETRO
 Distribuzione geografica
Continente #
NA - Nord America 4.354
AS - Asia 2.878
EU - Europa 2.201
SA - Sud America 893
AF - Africa 158
Continente sconosciuto - Info sul continente non disponibili 127
OC - Oceania 5
Totale 10.616
Nazione #
US - Stati Uniti d'America 4.127
SG - Singapore 1.038
BR - Brasile 655
CN - Cina 618
UA - Ucraina 555
VN - Vietnam 521
DE - Germania 448
IT - Italia 424
AT - Austria 182
FR - Francia 163
SE - Svezia 146
BD - Bangladesh 117
CA - Canada 113
IN - India 103
TR - Turchia 85
AR - Argentina 72
KR - Corea 69
FI - Finlandia 63
GB - Regno Unito 51
HK - Hong Kong 48
IQ - Iraq 48
SN - Senegal 43
CO - Colombia 37
ZA - Sudafrica 37
ID - Indonesia 36
EC - Ecuador 35
MX - Messico 34
RU - Federazione Russa 31
VE - Venezuela 27
PY - Paraguay 24
PK - Pakistan 23
PL - Polonia 19
MA - Marocco 18
NL - Olanda 18
BE - Belgio 17
MY - Malesia 16
PE - Perù 16
SA - Arabia Saudita 16
CL - Cile 15
PH - Filippine 15
DZ - Algeria 13
ES - Italia 13
AZ - Azerbaigian 12
AE - Emirati Arabi Uniti 11
JO - Giordania 11
LT - Lituania 11
TN - Tunisia 11
HN - Honduras 10
OM - Oman 10
UZ - Uzbekistan 10
CR - Costa Rica 9
EG - Egitto 9
JP - Giappone 9
KZ - Kazakistan 9
PA - Panama 9
TT - Trinidad e Tobago 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
KE - Kenya 8
CZ - Repubblica Ceca 7
IE - Irlanda 7
IR - Iran 7
JM - Giamaica 7
NG - Nigeria 7
SV - El Salvador 7
GT - Guatemala 6
LB - Libano 6
PS - Palestinian Territory 6
AL - Albania 5
AU - Australia 5
BG - Bulgaria 5
CW - ???statistics.table.value.countryCode.CW??? 5
GP - Guadalupe 5
KG - Kirghizistan 5
NI - Nicaragua 5
NP - Nepal 5
ET - Etiopia 4
IL - Israele 4
MK - Macedonia 4
PR - Porto Rico 4
RO - Romania 4
UY - Uruguay 4
AO - Angola 3
BH - Bahrain 3
EE - Estonia 3
GE - Georgia 3
LU - Lussemburgo 3
LV - Lettonia 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EU - Europa 2
HU - Ungheria 2
ME - Montenegro 2
QA - Qatar 2
RS - Serbia 2
TH - Thailandia 2
AM - Armenia 1
Totale 10.480
Città #
Ashburn 380
Singapore 364
Chandler 357
Jacksonville 338
San Jose 332
Council Bluffs 287
Dallas 275
San Mateo 220
Ho Chi Minh City 213
Dearborn 186
Boardman 181
Beijing 167
New York 152
Vienna 122
Hanoi 104
Milan 80
Lauterbourg 72
Seoul 69
Santa Clara 68
Shanghai 68
Izmir 67
Lawrence 63
Roxbury 63
São Paulo 61
Grafing 57
Ottawa 54
Munich 52
Los Angeles 51
Hong Kong 47
Rende 46
Des Moines 45
Helsinki 44
Dakar 43
Hefei 37
Bremen 36
Inglewood 35
Haiphong 31
Rome 30
Ann Arbor 29
Wilmington 29
Brooklyn 28
Toronto 25
Cambridge 23
Da Nang 23
Guangzhou 23
Phoenix 22
Chicago 19
Turku 19
Columbus 18
Rio de Janeiro 18
Baghdad 17
Johannesburg 17
Naples 17
Brussels 16
Orem 16
Pune 16
Cape Town 15
Seattle 15
Florence 14
London 14
San Francisco 14
Warsaw 14
Dhaka 13
Düsseldorf 13
Hanover 13
Miano 13
Ogden 13
The Dalles 13
Baku 12
Curitiba 12
Denver 12
Quito 12
Asunción 11
Atlanta 11
Belo Horizonte 11
Cosenza 11
Lima 11
Montreal 11
Redwood City 11
Amman 10
Falls Church 10
Tashkent 10
Tianjin 10
Amsterdam 9
Biên Hòa 9
Buenos Aires 9
Buffalo 9
Campinas 9
Caracas 9
Catanzaro 9
Frankfurt am Main 9
Guayaquil 9
Houston 9
Hải Dương 9
Medellín 9
Nanjing 9
Porto Alegre 9
Boston 8
Chennai 8
Goiânia 8
Totale 5.751
Nome #
17β-estradiol enhances α(5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells 275
3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression 269
A resveratrol derivative induces authophagic cell death in human breast cancer MCF-7 cell line. 237
A xenograft model highlights the dichotomic effects induced by adiponectin on cyclin D1 in human breast cancer cells accordingly to ERα expression. 233
A xenograft model highlights the dichotomic effects induced by adiponectin on cyclin D1 in human breast cancer cells accordingly to ERα expression 221
Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination 216
A new role of leptin as amplifier of estrogen signaling in breast cancer. 211
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer 208
DAX-1, as an androgen-target gene, inhibits aromatase expression: A novel mechanism blocking estrogendependent breast cancer cell proliferation 207
" L'attività antiproliferativa dell'oleuropeina e dell'idrossitirisolo nelle cellule di carcinoma mammario MCF-7 è associata all'inibizione delle MAP chinasi." 206
Omega-3 DHA- and EPA-dopamine conjugates induce PPARγ-dependent breast cancer cell death through autophagy and apoptosis 206
Conditional expression of Ki-RasG12V in the mammary epithelium of transgenic mice induces estrogen receptor alpha (ERα)-positive adenocarcinoma 204
Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor 200
Effects of Adiponectin on Cyclin D1 Expression in Breast Cancer Cells are Dependent on ER. 2nd Joint Meeting of Pathology and Laboratory Diagnostics, 2014 September 17-20, Palermo, Italy. Am J Pathol ,184(Suppl):S34 Abstract MTP1, 2014. Oral communication 198
Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells 198
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines 185
Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells 183
Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter 183
Effects of Adiponectin on Cyclin D1 Expression in Breast Cancer Cells are Dependent on ERα 179
Evidences that Estrogen Receptor alpha interferes with adiponectin effects on breast cancer cell growth 179
FoxO3a mediates the inhibitory effects of the antiepileptic drug Lamotrigine on breast cancer growth 179
Farnesoid X Receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through down-regulation of HER2 expression 171
Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells 170
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo 161
In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer. 158
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines 157
Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity 153
Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation 150
Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line 148
Effetti del TGF-β e del Bergaptene in line cellular di tumore mammario umano ERα(+) ed ERα(-) 147
Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth 146
Foxo3a inhibits tamoxifen-resistant breast cancer progression by inducing integrin α5 expression 146
Foxo3a re-expression overcomes tamoxifen resistance in breast cancer 140
Mammary Epithelium-Specific Conditional Expression of Human Mutant Ki-Ras in Mice Generates Estrogen Receptor Alpha (ER)-Positive Mammary Adenocarcinomas 139
Evidence that the mouse insulin receptor substrate-1 belongs to the gene family on which the promoter is activated by estrogen receptor alpha through its interaction with Sp1 131
FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity 119
Fas ligand expression in TM4 sertoli cells is enhanced by estradiol "in situ" production 119
Rapid estradiol/ER{alpha} signaling enhances aromatase enzymatic activity in breast cancer cells 117
Effetti modulatori dell’estradiolo prodotto in situ sull’espressione di Fas Ligand in una linea cellulare sertoliana:TM4 116
Evidence that estradiol, through a short non genomic loop, downregulates PTB1B and enhances aromatase activity in MCF7 cells 114
PI3-kinase/Akt pathway is involved in the short non genomic autocrine loop between 17-β estradiol and aromatase activity in MCF-7 cells. 114
Fas ligand in TM4 cells is up-regulated by estradiol through Estrogen Receptor alpha interaction with Sp-1 113
Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation 113
Production of Plant-Derived Oleuropein Aglycone by a Combined Membrane Process and Evaluation of Its Breast Anticancer Properties 113
Effetto up-regolatorio dell’estradiolo prodotto in situ sull’espressione di FAS-ligand nella linea cellulare sertoliana TM4 112
Evidence that estradiol through non genomic loop, downregulates PTP1B and enhances aromatase activity in MCF-7 cells 112
The antiepileptic drug Lamotrigine, through FoxO3a, inhibits breast cancer growth and development both in vitro and in vivo. Pellegrino M, Rizza P, Giordano F, Spina E, Ceraldi R, Andò S, Morelli C, Sisci D. 111
“Inhibitory role of Farnesoid X Receptor ligands aromatase expression in Leydig tumor cells” 110
Estrogen Receptor-β, through Sp1, Recruits a Corepressor Complex to the Estrogen Receptor-α Gene Promoter in Breast Cancer Cells 110
Evidence that farnesoid X receptor ligand through SF-1 responsive element inhibits aromatase expression in Leydig tumor cells 108
OHPg/PR-B Through Beclin1 Mediate Autophagy In Breast Cancer Cells 107
PI3-kinase/Akt pathway is involved in the short non genomic autocrine loop between 17-beta estradiol and aromatase activity in MCF-7 cells 106
Inhibitory role of Farnesoid X Receptor ligands on aromatase expression in Leydig tumor cells. 104
Evidences that Leptin Induces HER2 Expression and Enhances Stem Cells Population in Breast Cancer. 104
Evidence that PI3K/Akt pathway is involved in the short non genomic autocrine loop between 17beta-estradiol and aromatase activity in breast cancer 98
Nuclear compartimentalization of protein involved in cell survival is induced by low doses of paclitaxel: an early event which precedes block of MCF-7 cell cycle progression 96
First evidence of non-genomic estradiol induced up-regulation of aromatase enzymatic activity in MCF-7 breast cancer cells 96
Leptin induces functional activation of ERalpha and enhances aromatase expression in breast cancer cells 95
PPARγ ligands as antagonists of leptin signaling in breast cancer: in vivo and in vitro effects 93
PPAR-gamma ligand rosiglitazone counteracts the stimulatory effect of leptin on breast cancer growth 93
PPARγ ligand rosiglitazone counteracts the stimulatory effectsof leptin on breast cancer growth 91
Evidence that leptin induces HER2 expression and enhances the stem cell population in breast cancer 91
Leptin induces functional activity of ERalpha and stimulates aromatase expression in breast cancer cells: a new potential role on tumor progression 88
Farnesoid X receptor ligand down-regulates aromatase expression in Leydig tumor cells 85
PPARgamma ligands as antagonists of leptin signaling in breast cancer: in vivo and in vitro effects 83
Leptin stimulates aromatase expression and induces functional activaty of ERalpha in breast cancer cells: a new potential role on tumor progression. 83
Leptin induces functional activation of ERα and enhances aromatase expression in breast cancer cells 82
Leptin induces HER2 expression and enhances stem cells population in breast cancer. 78
PPAR gama ligand rosiglitazone counteracts the stimmulatory effect of leptin on breast cancer growth 75
Leptin stimulates, via MAPKinase, aromatase P II/1.3 promoter activity in MCF-7 cell line 71
The pMAPK/pAMPK ratio modulates the effect of adiponectin on breast cancer cell growth 71
Evidence that estradiol, through a short non genomic loop, downregulates PTP1B and enhances aromatase activity in MCF-7 cells 67
Leptin stimulates aromatase expression and induces functional activity of ERα in breast cancer cells: a new potential role on tumor progression 64
Fas Ligand expression in TM4 cells is up-regulated by estradiol through Estrogen Receptor alpha interaction via SP-1 62
Leptin stimulates, via MAPKinase, aromatase PII/I.3 promoter activity in MCF-7 cell line 53
null 40
Fas ligand expression in TM4 cells is up-regulated by estrdiol through Estrogen Receptor α interaction with Sp-1 37
null 34
null 31
null 30
null 29
null 29
null 28
null 27
Totale 10.616
Categoria #
all - tutte 53.778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.778


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022815 0 0 0 49 109 69 9 241 11 5 124 198
2022/2023922 135 110 45 99 128 73 24 94 101 19 70 24
2023/2024585 65 18 31 12 17 173 16 35 42 22 33 121
2024/20251.331 106 180 39 101 51 44 62 85 241 104 117 201
2025/20264.174 474 195 472 362 759 252 435 209 316 312 181 207
2026/2027997 225 147 204 421 0 0 0 0 0 0 0 0
Totale 10.616